Cardiorespiratory Diagnostic Study

CompletedOBSERVATIONAL
Enrollment

744

Participants

Timeline

Start Date

June 2, 2021

Primary Completion Date

November 2, 2022

Study Completion Date

November 30, 2022

Conditions
COPDAsthmaLung CancerAnemiaCongestive Cardiac FailureBronchiectasisInterstitial Lung DiseaseLong COVIDUpper Respiratory DiseaseHealthy
Interventions
DEVICE

N-Tidal C handset

Participants are to use the 'N-Tidal C' handset every day for 14 days. This will ideally be two times a day (once in the morning and once in the evening, before using any regular inhalers). Each breath record requires the participant to breathe through the mouthpiece for 75 seconds in a relaxed manner.

Trial Locations (1)

B19 1BP

Modality Partnership, Birmingham

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Innovate UK

OTHER_GOV

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

TidalSense

INDUSTRY

NCT04939558 - Cardiorespiratory Diagnostic Study | Biotech Hunter | Biotech Hunter